MDGL
MDGL
NASDAQ · Biotechnology

Madrigal Pharmaceuticals Inc

Mid-Cap Stocks Biotech Stocks Healthcare Stocks
$432.96
+0.17 (+0.04%)
Analyst Consensus
Strong Buy
26
Analysts
High
Coverage
Buy 24 92%
Hold 2 8%
Sell 0 0%
Price Target
Analyst Price Target -72.3% upside
Low Target $78.20
Average Target $119.83
High Target $127.79
Current Price $432.96
Current
$432.96
Target
$119.83
$78.20 $119.83 avg $127.79
Scenario Analysis
Bear Case
$78.20
-81.9%
Low target
Base Case
$119.83
-72.3%
Avg target
Bull Case
$127.79
+-70.5%
High target
Risk/Reward
0.9x
Unfavorable
Price in Context
52-Week High
$615.00
-29.6% from high
52-Week Low
$353.54
+22.5% from low
50-Day SMA
$484.73
-10.7% vs SMA
200-Day SMA
$497.36
-12.9% vs SMA
RSI (14)
36.0
Neutral
Target vs 52W High
$119.83
-80.5% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
 Strong Buy 38 82% $257.58 -12.4%
AMGN
Amgen Inc
 Hold 42 43% $190.87 -58.8%
GILD
Gilead Sciences Inc
 Strong Buy 36 83% $362.68 +113.5%
VRTX
Vertex Pharmaceuticals Inc
 Strong Buy 39 82% $438.34 -20.3%
MRNA
Moderna Inc
 Hold 31 32% $149.45 -42.1%
REGN
Regeneron Pharmaceuticals
 Buy 36 72% $76.80 -91.6%
NTRA
Natera Inc
 Strong Buy 31 90% $142.91 -54.5%
RVMD
Revolution Medicines Inc
 Strong Buy 31 94% $114.11 -40.3%